相似文献
1
Practical guidance for the management of adults with immune thrombocytopenia during the COVID-19 pandemic.
Br J Haematol. 2020 Jun;189(6):1038-1043. doi: 10.1111/bjh.16775. Epub 2020 Jun 2.
2
SARS-CoV-2 infection in two pediatric patients with immune cytopenias: A single institution experience during the pandemic.
Pediatr Blood Cancer. 2020 Sep;67(9):e28503. doi: 10.1002/pbc.28503. Epub 2020 Jun 21.
3
Immune Thrombocytopenia (ITP) in a Pediatric Patient Positive for SARS-CoV-2.
Pediatrics. 2020 Aug;146(2). doi: 10.1542/peds.2020-1419. Epub 2020 May 21.
4
Guidance for the management of adult patients with coronavirus disease 2019.
Chin Med J (Engl). 2020 Jul 5;133(13):1575-1594. doi: 10.1097/CM9.0000000000000899.
5
COVID-19-associated immune thrombocytopenia.
Br J Haematol. 2020 Jul;190(2):e61-e64. doi: 10.1111/bjh.16850. Epub 2020 Jun 8.
6
Coronavirus infection in cancer patients, last update.
Med Clin (Barc). 2020 Oct 9;155(7):299-301. doi: 10.1016/j.medcli.2020.05.028. Epub 2020 Jul 15.
7
Practical Guidance for Outpatient Spasticity Management During the Coronavirus (COVID-19) Pandemic: Canadian Spasticity COVID-19 Task Force.
Can J Neurol Sci. 2020 Sep;47(5):589-593. doi: 10.1017/cjn.2020.104. Epub 2020 May 26.
8
Severe SARS-CoV-2 infections: practical considerations and management strategy for intensivists.
Intensive Care Med. 2020 Apr;46(4):579-582. doi: 10.1007/s00134-020-05967-x. Epub 2020 Feb 26.
9
Severe immune thrombocytopenic purpura in critical COVID-19.
Int J Hematol. 2020 Nov;112(5):746-750. doi: 10.1007/s12185-020-02931-9. Epub 2020 Jul 1.
10
Consensus on interhospital transfers during the COVID-19 pandemic.
Emergencias. 2020;32(4):301-302.
引用本文的文献
1
Appropriate Management of Thrombotic Risk in Patients With Primary Immune Thrombocytopenia in the UK: A Modified Delphi Consensus.
EJHaem. 2025 Sep 3;6(5):e70134. doi: 10.1002/jha2.70134. eCollection 2025 Oct.
2
A case report of refractory immune thrombocytopenia: Challenges in choice of therapies in resource limiting center.
Int J Surg Case Rep. 2025 Jan;126:110704. doi: 10.1016/j.ijscr.2024.110704. Epub 2024 Nov 29.
3
Immune Thrombocytopenia Purpura Associated With COVID-19 Infection: A Challenging Diagnosis and Management.
Cureus. 2023 Oct 21;15(10):e47433. doi: 10.7759/cureus.47433. eCollection 2023 Oct.
4
Recommendations for the Clinical Approach to Immune Thrombocytopenia: Spanish ITP Working Group (GEPTI).
J Clin Med. 2023 Oct 10;12(20):6422. doi: 10.3390/jcm12206422.
5
Use and positioning of fostamatinib in the management of primary chronic immune thrombocytopenia: an Italian expert opinion.
Ther Adv Hematol. 2023 Feb 28;14:20406207221147777. doi: 10.1177/20406207221147777. eCollection 2023.
6
Knowledge mapping of immune thrombocytopenia: a bibliometric study.
Front Immunol. 2023 May 3;14:1160048. doi: 10.3389/fimmu.2023.1160048. eCollection 2023.
7
The Roles and Challenges of Advanced Therapies in the Management of Refractory Immune Thrombocytopenia: A Case Report and Review of the Literature.
Cureus. 2023 Mar 14;15(3):e36146. doi: 10.7759/cureus.36146. eCollection 2023 Mar.
8
Nationwide Survey on the Use of Thrombopoietin Receptor Agonists (TPO-RA) for the Management of Immune Thrombocytopenia in Current Clinical Practice in Italy.
Mediterr J Hematol Infect Dis. 2023 Mar 1;15(1):e2023019. doi: 10.4084/MJHID.2023.019. eCollection 2023.
9
Use of thrombopoietin receptor agonists in adults with immune thrombocytopenia: a systematic review and Central European expert consensus.
Ann Hematol. 2023 Apr;102(4):715-727. doi: 10.1007/s00277-023-05114-8. Epub 2023 Feb 24.
10
How we treat primary immune thrombocytopenia in adults.
J Hematol Oncol. 2023 Jan 19;16(1):4. doi: 10.1186/s13045-023-01401-z.
本文引用的文献
1
Pulmonary and cardiac pathology in African American patients with COVID-19: an autopsy series from New Orleans.
Lancet Respir Med. 2020 Jul;8(7):681-686. doi: 10.1016/S2213-2600(20)30243-5. Epub 2020 May 27.
2
Incidence of venous thromboembolism in hospitalized patients with COVID-19.
J Thromb Haemost. 2020 Aug;18(8):1995-2002. doi: 10.1111/jth.14888. Epub 2020 Jul 27.
3
Hypercoagulation and Antithrombotic Treatment in Coronavirus 2019: A New Challenge.
Thromb Haemost. 2020 Jun;120(6):949-956. doi: 10.1055/s-0040-1710317. Epub 2020 Apr 29.
4
Covid-19 in Immune-Mediated Inflammatory Diseases - Case Series from New York.
N Engl J Med. 2020 Jul 2;383(1):85-88. doi: 10.1056/NEJMc2009567. Epub 2020 Apr 29.
5
What do monitoring platelet counts in COVID-19 teach us?
J Thromb Haemost. 2020 Aug;18(8):2071-2072. doi: 10.1111/jth.14879. Epub 2020 May 12.
6
Thrombocytopenia and its association with mortality in patients with COVID-19.
J Thromb Haemost. 2020 Jun;18(6):1469-1472. doi: 10.1111/jth.14848. Epub 2020 May 4.
7
Immune Thrombocytopenic Purpura in a Patient with Covid-19.
N Engl J Med. 2020 Apr 30;382(18):e43. doi: 10.1056/NEJMc2010472. Epub 2020 Apr 15.
8
Incidence of thrombotic complications in critically ill ICU patients with COVID-19.
Thromb Res. 2020 Jul;191:145-147. doi: 10.1016/j.thromres.2020.04.013. Epub 2020 Apr 10.
9
Effect of regular intravenous immunoglobulin therapy on prognosis of severe pneumonia in patients with COVID-19.
J Infect. 2020 Aug;81(2):318-356. doi: 10.1016/j.jinf.2020.03.044. Epub 2020 Apr 10.
10
Attention should be paid to venous thromboembolism prophylaxis in the management of COVID-19.
Lancet Haematol. 2020 May;7(5):e362-e363. doi: 10.1016/S2352-3026(20)30109-5. Epub 2020 Apr 9.
Zotero 插件